Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp

doi:10.5306/wjco.v8.i5.405

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 5

This Article

(284)

(285)

(0)

(5709)

(7)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Cohort Study

World J Clin Oncol. Oct 10, 2017; 8(5): 405-411
Published online Oct 10, 2017. doi: 10.5306/wjco.v8.i5.405

Table 4 Multivariate logistic regression backward analysis¹

	OR	95%CI for OR		P value
	OR	Lower	Upper	P value
Head site	5.19	1.51	17.86	0.009^a
LSR composite day 2	1.46	1.08	1.97	0.014^a
Crusting day 8	1.94	1.18	3.20	0.009^a
LSR composite max	1.50	1.02	2.21	0.038^a

¹Factors predicting response to ingenol mebutate 0.015% therapy. Logistic backward multivariate regression model. Reported OR mutually adjusted for all variables in the model. Variables in the model: Gender: Male (M), female (F); head site: Scalp, face; erythema at day 2, 3, 8, 15, 29, 57 and max; crusting at day 8 and max; swelling at day 2, 3, 8 and max; vesiculation/pustulation at day 2, 3 and max; ulceration at day 3; LSR composite at day 2, 3, 8, 15 and max.

^aP < 0.05. OR: Odds ratio; LSR: Local skin reaction.

Full Size Table

Citation: Skroza N, Proietti I, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Tolino E, Zuber S, La Torre G, Potenza C. Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp. World J Clin Oncol 2017; 8(5): 405-411
URL: https://www.wjgnet.com/2218-4333/full/v8/i5/405.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i5.405

Skroza N, Proietti I, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Tolino E, Zuber S, La Torre G, Potenza C. Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp. World J Clin Oncol 2017; 8(5): 405-411 [PMID: 29067277 DOI: 10.5306/wjco.v8.i5.405]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.